Zika virus - Revision history

Mholtz at 08:27, 29 October 2018

2018-10-29T08:27:17Z

← Older revision		Revision as of 08:27, 29 October 2018
Line 36:		Line 36:
	***Referral to Maternal-Fetal medicine specialist if pregnant and exposed		***Referral to Maternal-Fetal medicine specialist if pregnant and exposed
	**Men: Consider using contraception or abstinence if recently travelled to endemic area and pregnant partner.		**Men: Consider using contraception or abstinence if recently travelled to endemic area and pregnant partner.

			==Disposition==
			*Should be made in consultation with CDC and ID.

	==Complications==		==Complications==

Hjaneway: /* Management */

2018-10-26T11:56:44Z

Management

← Older revision		Revision as of 11:56, 26 October 2018
Line 31:		Line 31:
	*Supportive care		*Supportive care
	**Hydration and antipyretic		**Hydration and antipyretic
	**Avoid [[NSAIDs]] until [[dengue]] excluded (risk of hemorrhage)<ref>Dick GW, Kitchen SF, Haddow AJ. Zika virus. I. Isolations and serological specificity. Trans R Soc Trop Med Hyg. 1952; 46(5): 509-20. PMID: 12995440</ref>		**Avoid [[NSAIDs]] and aspirin until [[dengue]] excluded (risk of hemorrhage)<ref>Dick GW, Kitchen SF, Haddow AJ. Zika virus. I. Isolations and serological specificity. Trans R Soc Trop Med Hyg. 1952; 46(5): 509-20. PMID: 12995440</ref>
	*Preventative care<ref>Centers for Disease Control and Prevention. Morbidity and Mortality Weekly Report: Interim guidelines for the evaluation and testing of infants with possible congenital Zika virus infection- United States 2016.</ref>		*Preventative care<ref>Centers for Disease Control and Prevention. Morbidity and Mortality Weekly Report: Interim guidelines for the evaluation and testing of infants with possible congenital Zika virus infection- United States 2016.</ref>
	**Women: Avoid travelling to endemic areas if pregnant		**Women: Avoid travelling to endemic areas if pregnant

Iwm5010: /* Complications */

2017-11-27T20:57:44Z

Complications

← Older revision		Revision as of 20:57, 27 November 2017
Line 39:		Line 39:
	==Complications==		==Complications==
	*Possible epidemiologic associations between Zika virus infection and:		*Possible epidemiologic associations between Zika virus infection and:
	*Adverse fetal outcomes (congenital microcephaly)		**Adverse fetal outcomes (congenital microcephaly)
	*[[Guillain-Barre syndrome]]<ref>European Centre for Disease Prevention and Control. Rapid risk assessment: Zika virus epidemic in the Americas: potential association with microcephaly and Guillain-Barré syndrome [PDF]. Stockholm, Sweden: European Centre for Disease Prevention and Control; 2015.</ref>		**[[Guillain-Barre syndrome]]<ref>European Centre for Disease Prevention and Control. Rapid risk assessment: Zika virus epidemic in the Americas: potential association with microcephaly and Guillain-Barré syndrome [PDF]. Stockholm, Sweden: European Centre for Disease Prevention and Control; 2015.</ref>
	*[[ITP]]		**[[ITP]]
	*[[Meningoencephalitis]]		**[[Meningoencephalitis]]
	*[[Transverse myelitis]]		**[[Transverse myelitis]]

	==See Also==		==See Also==

Iwm5010: /* Complications */

2017-11-27T20:57:08Z

Complications

← Older revision		Revision as of 20:57, 27 November 2017
Line 39:		Line 39:
	==Complications==		==Complications==
	*Possible epidemiologic associations between Zika virus infection and:		*Possible epidemiologic associations between Zika virus infection and:
	**Adverse fetal outcomes (congenital microcephaly)		*Adverse fetal outcomes (congenital microcephaly)
	**[[Guillain-Barre syndrome]]<ref>European Centre for Disease Prevention and Control. Rapid risk assessment: Zika virus epidemic in the Americas: potential association with microcephaly and Guillain-Barré syndrome [PDF]. Stockholm, Sweden: European Centre for Disease Prevention and Control; 2015.</ref>		*[[Guillain-Barre syndrome]]<ref>European Centre for Disease Prevention and Control. Rapid risk assessment: Zika virus epidemic in the Americas: potential association with microcephaly and Guillain-Barré syndrome [PDF]. Stockholm, Sweden: European Centre for Disease Prevention and Control; 2015.</ref>
	*[[ITP]]		*[[ITP]]
	*[[Meningoencephalitis]]		*[[Meningoencephalitis]]

Iwm5010: /* Clinical FeaturesCDC: Zika Virus: Clinical evaluation and disease */

2017-11-27T20:53:39Z

Clinical FeaturesCDC: Zika Virus: Clinical evaluation and disease

← Older revision		Revision as of 20:53, 27 November 2017
Line 15:		Line 15:
	*80% of patients are asymptomatic		*80% of patients are asymptomatic
	*Prodromal symptoms		*Prodromal symptoms
	**[[Fever]], [[maculopapular rash]], [[joint pain]], [[conjunctivitis]]		**[[Fever]], maculopapular rash, [[joint pain]], [[conjunctivitis]]
	**After incubation period of 2-14 days		**After incubation period of 2-14 days

Iwm5010: /* Clinical FeaturesCDC: Zika Virus: Clinical evaluation and disease */

2017-11-27T20:53:14Z

Clinical FeaturesCDC: Zika Virus: Clinical evaluation and disease

← Older revision		Revision as of 20:53, 27 November 2017
Line 15:		Line 15:
	*80% of patients are asymptomatic		*80% of patients are asymptomatic
	*Prodromal symptoms		*Prodromal symptoms
	**[[Fever]], [[rash]], [[joint pain]], [[conjunctivitis]]		**[[Fever]], [[maculopapular rash]], [[joint pain]], [[conjunctivitis]]
	**After incubation period of 2-7 days		**After incubation period of 2-14 days

	==Differential Diagnosis==		==Differential Diagnosis==

Iwm5010: /* Background */

2017-11-27T20:51:37Z

Background

← Older revision		Revision as of 20:51, 27 November 2017
Line 1:		Line 1:
	==Background==		==Background==
	*First reported case in US on Jan 13,2016 in patient who returned to Houston,TX after traveling to Latin America<ref>Faccini-Martínez ÁA, Botero-García CA, Benítez-Baracaldo FC, Pérez-Díaz CE. With regard about the case of Dengue, Chikungunya and Zika co-infection in a patient from Colombia. J Infect Public Health. 2016. PMID: 26837723</ref>		*First reported case in US on Jan 13, 2016 in patient who returned to Houston,TX after traveling to Latin America<ref>Faccini-Martínez ÁA, Botero-García CA, Benítez-Baracaldo FC, Pérez-Díaz CE. With regard about the case of Dengue, Chikungunya and Zika co-infection in a patient from Colombia. J Infect Public Health. 2016. PMID: 26837723</ref>
	*Transmitted to humans through<ref>Hayes EB. Zika virus outside Africa. Emerg Infect Dis. 2009;15:1347–50.</ref>:		*Transmitted to humans through<ref>Hayes EB. Zika virus outside Africa. Emerg Infect Dis. 2009;15:1347–50.</ref>:
	**Bites from Aedes mosquito		**Bites from Aedes mosquito

ClaireLewis: /* Complications */

2016-11-13T23:55:07Z

Complications

← Older revision		Revision as of 23:55, 13 November 2016
Line 40:		Line 40:
	*Possible epidemiologic associations between Zika virus infection and:		*Possible epidemiologic associations between Zika virus infection and:
	**Adverse fetal outcomes (congenital microcephaly)		**Adverse fetal outcomes (congenital microcephaly)
	**[[~~Guillan~~-Barre syndrome]]<ref>European Centre for Disease Prevention and Control. Rapid risk assessment: Zika virus epidemic in the Americas: potential association with microcephaly and Guillain-Barré syndrome [PDF]. Stockholm, Sweden: European Centre for Disease Prevention and Control; 2015.</ref>		**[[Guillain-Barre syndrome]]<ref>European Centre for Disease Prevention and Control. Rapid risk assessment: Zika virus epidemic in the Americas: potential association with microcephaly and Guillain-Barré syndrome [PDF]. Stockholm, Sweden: European Centre for Disease Prevention and Control; 2015.</ref>
	*[[ITP]]		*[[ITP]]
	*[[Meningoencephalitis]]		*[[Meningoencephalitis]]

ClaireLewis: /* Complications */

2016-11-13T23:54:21Z

Complications

← Older revision		Revision as of 23:54, 13 November 2016
Line 40:		Line 40:
	*Possible epidemiologic associations between Zika virus infection and:		*Possible epidemiologic associations between Zika virus infection and:
	**Adverse fetal outcomes (congenital microcephaly)		**Adverse fetal outcomes (congenital microcephaly)
	**Guillan-Barre syndrome<ref>European Centre for Disease Prevention and Control. Rapid risk assessment: Zika virus epidemic in the Americas: potential association with microcephaly and Guillain-Barré syndrome [PDF]. Stockholm, Sweden: European Centre for Disease Prevention and Control; 2015.</ref>		**[[Guillan-Barre syndrome]]<ref>European Centre for Disease Prevention and Control. Rapid risk assessment: Zika virus epidemic in the Americas: potential association with microcephaly and Guillain-Barré syndrome [PDF]. Stockholm, Sweden: European Centre for Disease Prevention and Control; 2015.</ref>
	*ITP		*[[ITP]]
	*Meningoencephalitis		*[[Meningoencephalitis]]
	*Transverse myelitis		*[[Transverse myelitis]]

	==See Also==		==See Also==

Neil.m.young: Text replacement - "==Diagnosis==" to "==Evaluation=="

2016-07-23T01:22:52Z

Text replacement - "==Diagnosis==" to "==Evaluation=="

← Older revision		Revision as of 01:22, 23 July 2016
Line 23:		Line 23:
	{{Travel Skin Conditions DDX}}		{{Travel Skin Conditions DDX}}

	==~~Diagnosis~~==		==Evaluation==
	*Clinical diagnosis		*Clinical diagnosis
	*Testing via PCR and IgM antibody assays via CDC or health department		*Testing via PCR and IgM antibody assays via CDC or health department